Kodu・Aktsiate loetelu・Neogen Corp

Neogen Corp

Suletud

SektorTervishoid

11.59 -3.01

Osta Müü

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

11.81

Max

11.98

Põhinäitajad
By Trading Economics
Sissetulek	5.7M -11M
Müük	14M 225M
Aktsiakasum	0.08
Kasumimarginaal	-5.016
Töötajad	2,636
EBITDA	14M 37M

Soovitused
By TipRanks
Soovitused	Osta
12 kuu keskmine prognoos	+4.6% upside

Dividendid
By Acuity
Järgmine tulemuste avaldamine	8. okt 2026

Turustatistika
By TradingEconomics
Turukapital	555M 2.6B
Eelmine avamishind	14.6
Eelmine sulgemishind	11.59

Uudiste sentiment

By Acuity

25%

75%

56 / 340 Pingereas Healthcare

Neogen Corp Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

21. aug 2026, 21:01 UTC

Neogen Corp is gaining in after-market trading, continuing an increase since Friday's close. The stock remains above its 20-day moving average.

19. aug 2026, 20:02 UTC

Neogen Corp shares are higher during Wednesday's session, reflecting a broader market trend. The stock is above its 20-day moving average.

18. aug 2026, 19:36 UTC

Neogen Corp shares are lower today amid cautious market sentiment and rising treasury yields. The stock remains above its 20-day moving average.

17. aug 2026, 22:36 UTC

Neogen Corp's shares are lower in after-market hours with no specific news identified. Broader market volatility is influenced by geopolitical tensions in the Middle East.

13. aug 2026, 20:06 UTC

Neogen Corp shares are higher during Thursday's session, tracking broader market gains. The stock trades above its 20-day moving average amid positive momentum.

12. aug 2026, 22:02 UTC

Neogen Corp shares declined in after-market hours, following a notable drop earlier. No specific news was identified to explain the movement.

11. aug 2026, 20:01 UTC

Neogen Corp shares are higher today, having peaked shortly after the market opened. The stock remains above its 20-day moving average.

6. aug 2026, 19:16 UTC

Neogen Corp shares are lower, continuing a decline over four sessions. No specific news was identified to explain today's price movement.

5. aug 2026, 19:21 UTC

Neogen Corp's shares are lower today, following a volatile trading session with no specific news identified for the decline.

4. aug 2026, 19:46 UTC

Neogen Corp shares are lower today, with no specific news driving the decline. The stock remains above its 20-day moving average amid broader market strength.

3. aug 2026, 19:46 UTC

News

Piper Sandler raised its price target on Neogen Corp to $13 from $11. Shares are trading roughly flat during Monday's session.

31. juuli 2026, 20:02 UTC

News

Neogen Corporation narrowed its net loss to $11.3 million for Q4 2026, with shares advancing during Friday's session amid optimistic revenue guidance for fiscal 2027.

30. juuli 2026, 20:09 UTC

Neogen Corp shares are trading higher, continuing a strong upward trend since Wednesday amid mixed economic signals and overall market volatility.

29. juuli 2026, 16:56 UTC

News

Neogen Corp shares are advancing as the company prepares to report Q2 earnings, with analysts expecting a revenue decline of 5.7% year on year.

24. juuli 2026, 18:56 UTC

Neogen Corp. shares are lower, continuing a six-session decline. The broader market is affected by falling oil prices, impacting investor sentiment.

22. juuli 2026, 19:46 UTC

Neogen Corp shares are lower today, extending a four-day decline. Broader market conditions are pressured by rising crude oil prices and geopolitical tensions.

21. juuli 2026, 18:01 UTC

Neogen Corp. shares are trading roughly flat amid no specific news. The stock remains near the upper end of its one-month range.

Võrdlus sarnastega

Hinnamuutus

Neogen Corp Prognoos

Hinnasiht

By TipRanks

4.6% tõus

12 kuu keskmine prognoos

Keskmine 12.5 USD 4.6%

Kõrge 13 USD

Madal 12 USD

Põhineb 3 Wall Streeti analüütiku instrumendi Neogen Corp 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Osta

3 ratings

Osta

Hoia

Müü

Põhineb 3 analüütiku instrumendi Neogen Corp aktsia reitingul - viimase 3 kuu andmed.

Sentiment

By Acuity

56 / 340 Pingereas Tervishoid

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

Ettevõttest Neogen Corp

Neogen Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide. It operates through two segments, Food Safety and Animal Safety. The Food Safety segment offers diagnostic test kits and related products to detect dangerous and unintended substances in food and animal feed, including foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns, as well as food quality and nutritional components. It also provides AccuPoint Advanced rapid sanitation test to detect the presence of adenosine triphosphate, a chemical found in living cells, as well as provides genomics-based diagnostic technology and software systems that help testers to objectively analyze and store their results and perform analysis on the results from multiple locations over extended periods. The segment offers its products primarily to milling and grain, meat and poultry, prepared food products and ingredients, fruits and vegetables, seafood, dairy, beverage, water, healthcare, traditional culture media markets, food service, and dietary supplements markets. The Animal Safety segment provides veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products, and genomics testing services marketed through veterinarians, retailers, livestock producers, and animal health product distributors, for the animal safety market. The segment offers its products for companion animal veterinarians; livestock producers, veterinarians, and breed associations; retailers; breeding and genetics companies; diagnostic labs and universities; distributors; and other manufacturers and government agencies. The company was incorporated in 1981 and is headquartered in Lansing, Michigan.